Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

Stock Information for Quantum Biopharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Quantum Biopharma Ltd.

Clene Announces $4 Million Registered Direct Offering
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
Clene to Present at Upcoming September Investor Conferences
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
Clene to Present at the Emerging Growth Conference
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
Clene to Present at The Canaccord 46th Annual Growth Conference
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.